News from milliporesigma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 18, 2022, 12:00 ET MilliporeSigma Breaks Ground on Company's First Lateral Flow Membrane Production Facility in the United States

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today broke...

Jun 23, 2022, 09:00 ET MilliporeSigma Opens US$ 65 Million CDMO Facility to Address Demand for Critical Cancer Therapies

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has doubled...

May 18, 2022, 08:00 ET MilliporeSigma Announces the Expansion of Hands-On Science Education Program with Kick-off of Global Curiosity Cube® Mobile Lab

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today...

Apr 05, 2022, 14:00 ET MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, today announced ...

Feb 23, 2022, 08:40 ET MilliporeSigma Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-Up

MilliporeSigma, the U.S. and Canada Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today...

Feb 07, 2022, 09:05 ET MilliporeSigma Announces Organizational Transformation to Strengthen CDMO Offering and Accelerate Future Growth

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today...

Dec 29, 2021, 17:15 ET MilliporeSigma Announces $136.7 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today...

Oct 28, 2021, 09:00 ET MilliporeSigma Announces New Innovation & Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies

- MilliporeSigma's unique technology, ChetoSensar™, gives new promise to ADCs by alleviating solubility challenges - New DOLCORE™ platform increases...

Oct 12, 2021, 09:00 ET MilliporeSigma Announces Completion of New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment...

Oct 06, 2021, 08:00 ET MilliporeSigma's Danvers Facility Honored as a Manufacturer of the Year by Commonwealth's Legislative Manufacturing Caucus

MilliporeSigma, the U.S. and Canadian life science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, was selected ...

May 26, 2021, 08:00 ET MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid-19 Demand

To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, MilliporeSigma has launched a new, high-purity synthetic ...

Mar 17, 2021, 11:40 ET MilliporeSigma Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies

MilliporeSigma will add a single-use assembly production unit at its Life Science Center in Molsheim, France. With the $30 million investment, the...

Jan 07, 2021, 04:00 ET MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

MilliporeSigma today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization...

Dec 07, 2020, 08:00 ET MilliporeSigma Expands Production Capacities

MilliporeSigma today announced the broadening of its manufacturing footprint with a combined $47 million investment at its production facilities in...

Oct 08, 2020, 08:30 ET MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant

MilliporeSigma today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany. With the new facility, the...

Oct 06, 2020, 13:00 ET MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant

MilliporeSigma today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location. The upgraded system...

Sep 09, 2020, 09:00 ET MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion

MilliporeSigma today announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison,...

Jul 10, 2020, 01:00 ET MilliporeSigma Opens its Largest M Lab™ Collaboration Center in Shanghai

...
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

May 27, 2020, 09:15 ET MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

MilliporeSigma and Baylor College of Medicine today announced an extension of their ongoing collaboration to advance a manufacturing platform to...

May 11, 2020, 09:00 ET MilliporeSigma Granted U.S. Patents for Foundational CRISPR-Cas9 Technology

MilliporeSigma, a leader in genome editing, today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the...

Apr 14, 2020, 08:00 ET MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

MilliporeSigma and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19...

Apr 07, 2020, 08:00 ET MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology

MilliporeSigma, a leader in genome editing, today announced that the United States Patent and Trademark Office has granted the company's patent for...

Mar 03, 2020, 14:00 ET MilliporeSigma's New LANEXO™ System to Improve Scientists' Productivity in the Lab

MilliporeSigma today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution...

Dec 19, 2019, 08:00 ET MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega

MilliporeSigma, a leader in genome editing, today announced that it has signed a license agreement providing Promega Corp., a global life science...

Nov 26, 2019, 08:00 ET Japan and Singapore Grant CRISPR Patents to MilliporeSigma

MilliporeSigma today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed its patent...